Growth hormone treatment in adolescent males with idiopathic short stature: Changes in body composition, protein, fat, and glucose metabolism

Tamara Hannon, Kapriel Danadian, Chittiwat Suprasongsin, Silva A. Arslanian

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Context: Cross-sectional observations show an inverse relationship between pubertal increase in GH and insulin sensitivity, suggesting that pubertal insulin resistance may be mediated by GH. Objective: Our objective was to assess longitudinally the effects of short-term GH supplementation in adolescent males with non-GH-deficient idiopathic short stature (ISS) on body composition, substrate metabolism, and insulin sensitivity. Children with ISS were studied to simulate the pubertal increase in GH secretion. Participants and Setting: Eight males with ISS (10.8-16.5 yr) were recruited from pediatric endocrinology clinics at an academic medical center. Study Design: Participants were evaluated in the General Clinical Research Center before and after 4 months of GH supplementation (0.3 mg/kg·wk). Body composition was assessed with dual-energy x-ray absorptiometry. Whole-body glucose, protein, and fat turnover were measured using stable isotopes. In vivo insulin action was assessed during a 3-h hyperinsulinemic (40 mU/m2·min) euglycemic clamp. Results: GH supplementation led to 1) increase in hepatic glucose production and fasting insulin levels, 2) increase in lean body mass and decrease in fat mass, and 3) improvement in cardiovascular lipid risk profile. Plasma IGF-I levels correlated positively with insulin levels. Conclusions: Four months of GH supplementation in adolescent males with ISS is associated with significant body composition changes and hepatic insulin resistance.

Original languageEnglish (US)
Pages (from-to)3033-3039
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume92
Issue number8
DOIs
StatePublished - Aug 2007
Externally publishedYes

Fingerprint

Body Composition
Metabolism
Growth Hormone
Insulin Resistance
Fats
Insulin
Glucose
Chemical analysis
Proteins
Glucose Clamp Technique
Endocrinology
Liver
Therapeutics
Insulin-Like Growth Factor I
Isotopes
Fasting
X-Rays
Pediatrics
Lipids
Clamping devices

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Growth hormone treatment in adolescent males with idiopathic short stature : Changes in body composition, protein, fat, and glucose metabolism. / Hannon, Tamara; Danadian, Kapriel; Suprasongsin, Chittiwat; Arslanian, Silva A.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 92, No. 8, 08.2007, p. 3033-3039.

Research output: Contribution to journalArticle

@article{7e86a307977e4ebcaf1e118257f7d475,
title = "Growth hormone treatment in adolescent males with idiopathic short stature: Changes in body composition, protein, fat, and glucose metabolism",
abstract = "Context: Cross-sectional observations show an inverse relationship between pubertal increase in GH and insulin sensitivity, suggesting that pubertal insulin resistance may be mediated by GH. Objective: Our objective was to assess longitudinally the effects of short-term GH supplementation in adolescent males with non-GH-deficient idiopathic short stature (ISS) on body composition, substrate metabolism, and insulin sensitivity. Children with ISS were studied to simulate the pubertal increase in GH secretion. Participants and Setting: Eight males with ISS (10.8-16.5 yr) were recruited from pediatric endocrinology clinics at an academic medical center. Study Design: Participants were evaluated in the General Clinical Research Center before and after 4 months of GH supplementation (0.3 mg/kg·wk). Body composition was assessed with dual-energy x-ray absorptiometry. Whole-body glucose, protein, and fat turnover were measured using stable isotopes. In vivo insulin action was assessed during a 3-h hyperinsulinemic (40 mU/m2·min) euglycemic clamp. Results: GH supplementation led to 1) increase in hepatic glucose production and fasting insulin levels, 2) increase in lean body mass and decrease in fat mass, and 3) improvement in cardiovascular lipid risk profile. Plasma IGF-I levels correlated positively with insulin levels. Conclusions: Four months of GH supplementation in adolescent males with ISS is associated with significant body composition changes and hepatic insulin resistance.",
author = "Tamara Hannon and Kapriel Danadian and Chittiwat Suprasongsin and Arslanian, {Silva A.}",
year = "2007",
month = "8",
doi = "10.1210/jc.2007-0308",
language = "English (US)",
volume = "92",
pages = "3033--3039",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - Growth hormone treatment in adolescent males with idiopathic short stature

T2 - Changes in body composition, protein, fat, and glucose metabolism

AU - Hannon, Tamara

AU - Danadian, Kapriel

AU - Suprasongsin, Chittiwat

AU - Arslanian, Silva A.

PY - 2007/8

Y1 - 2007/8

N2 - Context: Cross-sectional observations show an inverse relationship between pubertal increase in GH and insulin sensitivity, suggesting that pubertal insulin resistance may be mediated by GH. Objective: Our objective was to assess longitudinally the effects of short-term GH supplementation in adolescent males with non-GH-deficient idiopathic short stature (ISS) on body composition, substrate metabolism, and insulin sensitivity. Children with ISS were studied to simulate the pubertal increase in GH secretion. Participants and Setting: Eight males with ISS (10.8-16.5 yr) were recruited from pediatric endocrinology clinics at an academic medical center. Study Design: Participants were evaluated in the General Clinical Research Center before and after 4 months of GH supplementation (0.3 mg/kg·wk). Body composition was assessed with dual-energy x-ray absorptiometry. Whole-body glucose, protein, and fat turnover were measured using stable isotopes. In vivo insulin action was assessed during a 3-h hyperinsulinemic (40 mU/m2·min) euglycemic clamp. Results: GH supplementation led to 1) increase in hepatic glucose production and fasting insulin levels, 2) increase in lean body mass and decrease in fat mass, and 3) improvement in cardiovascular lipid risk profile. Plasma IGF-I levels correlated positively with insulin levels. Conclusions: Four months of GH supplementation in adolescent males with ISS is associated with significant body composition changes and hepatic insulin resistance.

AB - Context: Cross-sectional observations show an inverse relationship between pubertal increase in GH and insulin sensitivity, suggesting that pubertal insulin resistance may be mediated by GH. Objective: Our objective was to assess longitudinally the effects of short-term GH supplementation in adolescent males with non-GH-deficient idiopathic short stature (ISS) on body composition, substrate metabolism, and insulin sensitivity. Children with ISS were studied to simulate the pubertal increase in GH secretion. Participants and Setting: Eight males with ISS (10.8-16.5 yr) were recruited from pediatric endocrinology clinics at an academic medical center. Study Design: Participants were evaluated in the General Clinical Research Center before and after 4 months of GH supplementation (0.3 mg/kg·wk). Body composition was assessed with dual-energy x-ray absorptiometry. Whole-body glucose, protein, and fat turnover were measured using stable isotopes. In vivo insulin action was assessed during a 3-h hyperinsulinemic (40 mU/m2·min) euglycemic clamp. Results: GH supplementation led to 1) increase in hepatic glucose production and fasting insulin levels, 2) increase in lean body mass and decrease in fat mass, and 3) improvement in cardiovascular lipid risk profile. Plasma IGF-I levels correlated positively with insulin levels. Conclusions: Four months of GH supplementation in adolescent males with ISS is associated with significant body composition changes and hepatic insulin resistance.

UR - http://www.scopus.com/inward/record.url?scp=34547814687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547814687&partnerID=8YFLogxK

U2 - 10.1210/jc.2007-0308

DO - 10.1210/jc.2007-0308

M3 - Article

C2 - 17519313

AN - SCOPUS:34547814687

VL - 92

SP - 3033

EP - 3039

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 8

ER -